期刊文献+

Comparative effectiveness and safety of ribavirin plus interferon-alpha,lopinavir/ritonavir plus interferon-alpha,and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019:study protocol 被引量:2

原文传递
导出
摘要 To the Editor:At the end of 2019,an outbreak of novel coronavirus disease 2019(COVID-19),caused by 2019-nCov,causing widespread novel coronavirus disease.This outbreak of COVID-19 occurred during the period of the 2020 Spring Festival in China,a period known for massive population movements within China.This has resulted in large numbers of infected patients as a consequence of multiple human contact episodes in individual travelers.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2020年第9期1132-1134,共3页 中华医学杂志(英文版)
基金 This work was supported by the Chongqing Special Research Project for Prevention and Control of Novel Coronavirus Pneumonia(No.cstc2020jscx-fyzx0074)。
  • 相关文献

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部